Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

被引：0
|
作者：
Anum, Babar [1 ]
Hina, Zubair [2 ]
Mainoma, Bano [3 ]
Sana, Rafique [4 ]
Arzu, Shahid [1 ]
Maham, Babar
Waleed, Madeeha S. [5 ]
Arslan, Inayat [6 ]
Danish, Safi [7 ]
机构：
[1] Khyber Girls Med Coll, Karachi, Pakistan
[2] Rawalpindi Med Univ, Rawalpindi, Pakistan
[3] Deccan Coll Med Sci, Hyderabad, India
[4] Liaquat Natl Med Coll, Karachi, Pakistan
[5] Lower Bucks Hosp, Bristol, PA USA
[6] HSHS St Mary Hosp, Decatur, IL USA
[7] JW Ruby Mem Hosp, Morgantown, WV USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-046
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [41] Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
    Chari, Ajai
    Florendo, Erika
    Mancia, Ines Stefania
    Cho, Hearn
    Madduri, Deepu
    Parekh, Samir
    Richter, Josh
    Dhadwal, Amishi
    Thomas, Joanne
    Jiang, Grace
    Lagana, Alessandro
    Bhalla, Sherry
    Jagannath, Sundar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : E975 - E984
  • [42] EFFICACY AND SAFETY OF SELINEXOR FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS
    Abushanab, D.
    Mraiche, F.
    Al-Badriyeh, D.
    [J]. VALUE IN HEALTH, 2021, 24 : S22 - S22
  • [43] Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor
    Tomer, Mark
    Lucio, Gordan
    David, Ray
    Stephen, Ijioma
    George, Dranitsaris
    Amanda, Warner
    Trevor, Heritage
    Matthew, Fink
    David, Wenk
    Shachar, Peles
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S24 - S24
  • [44] Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    LeBlanc, Richard
    Baljevic, Muhamed
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Venner, Christopher P.
    Gasparetto, Cristina
    Chen, Christine I.
    Lipe, Brea
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    Callander, Natalie S.
    Bensinger, William I.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Zhou, Tianjun
    Kazuharu, Kai
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Schiller, Gary J.
    [J]. BLOOD, 2020, 136
  • [45] Daratumumab with Pomalidomide and Dexamethasone at First Relapse in Relapsed and/or Refractory Multiple Myeloma ( RRMM) Patients
    不详
    [J]. BLOOD, 2021, 138
  • [46] Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Berenson, James R.
    Silagan, Noemi
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Sanchez, Armando J.
    Forouzan, Eli
    Swift, Regina
    Eades, Benjamin
    Schwartz, Gary
    Eshaghian, Shahrooz
    Boccia, Ralph V.
    Yang, Honghao Hank
    Lim, Stephen
    Vescio, Robert
    [J]. BLOOD, 2020, 136
  • [47] PRACTICE PATTERNS AND OUTCOMES IN ELDERLY US PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Romanus, D.
    Raju, A.
    Yong, C.
    Seal, B.
    Farrelly, E.
    Labotka, R.
    Jhaveri, M.
    Noga, S.
    Blazer, M.
    Parameswaran, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 532 - 533
  • [48] Phase I trial of the combination of selinexor (SEL), liposomal doxorubicin (DOX) and dexamethasone (Dex) for relapsed and refractory multiple myeloma (RRMM).
    Baz, Rachid C.
    Shain, Kenneth H.
    Alsina, Melissa
    Brayer, Jason
    Rashal, Tami
    Cooksey, Jennifer L.
    Turner, Joel G.
    Dawson, Jana
    Sullivan, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
    Bassali, Jan
    Gould, Ian Gopal
    Kaye, James A.
    Mladsi, Deirdre
    Mehta, Jyotsna
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 317 - 325
  • [50] Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia
    Chen, Christine
    Siegel, David
    Gutierrez, Martin
    Jacoby, Meagan
    Hofmeister, Craig C.
    Gabrail, Nashat
    Baz, Rachid
    Mau-Sorensen, Morten
    Berdeja, Jesus G.
    Savona, Michael
    Savoie, Lynn
    Trudel, Suzanne
    Areethamsirikul, Nuchanan
    Unger, T. J.
    Rashal, Tami
    Hanke, Tim
    Kauffman, Michael
    Shacham, Sharon
    Reece, Donna
    [J]. BLOOD, 2018, 131 (08) : 855 - 863
12345